Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Clinical trial NCT05755386 · RECRUITING
Trial details
- NCT number
- NCT05755386
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-02
- Primary completion
- 2028-10-27
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.